[HTML][HTML] Manipulating gene expression levels in mammalian cell factories: An outline of synthetic molecular toolboxes to achieve multiplexed control

P Eisenhut, N Marx, G Borsi, M Papež, C Ruggeri… - New …, 2024 - Elsevier
Mammalian cells have developed dedicated molecular mechanisms to tightly control
expression levels of their genes where the specific transcriptomic signature across all genes …

Genetic engineering approaches to improve posttranslational modification of biopharmaceuticals in different production platforms

T Amann, V Schmieder… - Biotechnology and …, 2019 - Wiley Online Library
The number of approved biopharmaceuticals, where product quality attributes remain of
major importance, is increasing steadily. Within the available variety of expression hosts, the …

Modeling apoptosis resistance in CHO cells with CRISPR‐mediated knockouts of Bak1, Bax, and Bok

MA MacDonald, C Barry, T Groves… - Biotechnology and …, 2022 - Wiley Online Library
Chinese hamster ovary (CHO) cells are the primary platform for the production of
biopharmaceuticals. To increase yields, many CHO cell lines have been genetically …

Let's make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment

M Bayat, JS Nahand - Cell Biology and Toxicology, 2024 - Springer
Advancements in the CRISPR technology, a game-changer in experimental research, have
revolutionized various fields of life sciences and more profoundly, cancer research. Cell …

Attenuating apoptosis in Chinese hamster ovary cells for improved biopharmaceutical production

MN Henry, MA MacDonald, CA Orellana… - Biotechnology and …, 2020 - Wiley Online Library
Chinese hamster ovary (CHO) cells are the predominant host cell line for the production of
biopharmaceuticals, a growing industry currently worth more than $188 billion USD in global …

[HTML][HTML] Improving recombinant protein production in CHO cells using the CRISPR-Cas system

AK Kalkan, F Palaz, S Sofija, N Elmousa… - Biotechnology …, 2023 - Elsevier
Chinese hamster ovary (CHO) cells are among the most widely used mammalian cell lines
in the biopharmaceutical industry. Therefore, it is not surprising that significant efforts have …

CHO cell productivity improvement by genome-scale modeling and pathway analysis: Application to feed supplements

Z Huang, J Xu, A Yongky, CS Morris, AL Polanco… - Biochemical …, 2020 - Elsevier
Effective bioprocess development using Chinese hamster ovary (CHO) cells as hosts is
hampered by the limited understanding of cellular metabolism under process conditions in …

Restoration of DNA repair mitigates genome instability and increases productivity of Chinese hamster ovary cells

PN Spahn, X Zhang, Q Hu, H Lu… - Biotechnology and …, 2022 - Wiley Online Library
Chinese hamster ovary (CHO) cells are the primary host for manufacturing of therapeutic
proteins. However, productivity loss is a major problem and is associated with genome …

Awakening dormant glycosyltransferases in CHO cells with CRISPRa

KJC Karottki, H Hefzi, K **ong, I Shamie… - Biotechnology and …, 2020 - Wiley Online Library
Chinese hamster ovary (CHO) cells are the preferred workhorse for the biopharmaceutical
industry, and CRISPR/Cas9 has proven powerful for generating targeted gene perturbations …

An optimized genome-wide, virus-free CRISPR screen for mammalian cells

K **ong, KJ la Cour Karottki, H Hefzi, S Li, LM Grav… - Cell Reports …, 2021 - cell.com
Pooled CRISPR screens have been widely applied to mammalian and other organisms to
elucidate the interplay between genes and phenotypes of interest. The most popular method …